Drugs / ARK-E021
last change Oct 2013 re-read 3 minutes ago

ARK-E021

Developed for
acne
Investigated by
M. Arkin 1999 Ltd. · Vyne Therapeutics Inc.

Trials 1

201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT01494285 Jun 2012 → Oct 2013 acne M. Arkin 1999 Ltd. Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as ARK-E021 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01494285 ↗
Route Topical “Topically applied once daily at bedtime” NCT01494285 ↗